Cramp-Fasciculation Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Cramp-Fasciculation Syndrome

Who are the top Cramp-Fasciculation Syndrome Local Doctors?
Mohammad A. Khoshnoodi
Advanced in Cramp-Fasciculation Syndrome
Advanced in Cramp-Fasciculation Syndrome

Reading Hospital

420 South 5th Avenue, 
West Reading, PA 
Languages Spoken:
English

. Dr. Khoshnoodi is rated as an Advanced provider by MediFind in the treatment of Cramp-Fasciculation Syndrome. His top areas of expertise are Peripheral Neuropathy, Guillain-Barre Syndrome, Chronic Polyradiculoneuritis, and Miller-Fisher Syndrome.

Elite in Cramp-Fasciculation Syndrome
Elite in Cramp-Fasciculation Syndrome
Munich, BY, DE 

Benedikt Schoser practices in Munich, Germany. Mr. Schoser is rated as an Elite expert by MediFind in the treatment of Cramp-Fasciculation Syndrome. His top areas of expertise are Myotonic Dystrophy Type 2, Myotonic Dystrophy, Paramyotonia Congenita, Pompe Disease, and Thymectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Cramp-Fasciculation Syndrome
Elite in Cramp-Fasciculation Syndrome
Brussels, BRU, BE 

Michel Toussaint practices in Brussels, Belgium. Mr. Toussaint is rated as an Elite expert by MediFind in the treatment of Cramp-Fasciculation Syndrome. His top areas of expertise are Cramp-Fasciculation Syndrome, Duchenne Muscular Dystrophy, Swallowing Difficulty, and Becker Muscular Dystrophy.

What are the latest Cramp-Fasciculation Syndrome Clinical Trials?
A Prospective, Interventional, Baseline Study In Young Male Subjects Aged From 4 to 9 Years

Summary: Baseline Study on Duchenne Muscular Dystrophy (DMD) in view to collect data on the natural disease course in a cohort in young male subjects aged from 4 to 9 Years over a period of 6 to 36 months using disease appropriate evaluations.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)

Summary: This phase Ib trial studies the side effects of nivolumab and to see how well it works in treating patients with autoimmune disorders and cancer that has spread to other places in the body or cannot removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and sprea...

Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center